Critical Care

official impact factor 4.60

Open Access Highly Access

Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study

Sari Karlsson*, Milja Heikkinen, Ville Pettilä, Seija Alila, Sari Väisänen, Kari Pulkki, Elina Kolho, Esko Ruokonen and the Finnsepsis Study Group

Critical Care 2010, 14:R205 doi:10.1186/cc9327


See related commentary by Wolff and Bouadma, http://ccforum.com/content/14/6/1007

Accesses  

  • Last 30 days: 143 accesses
  • Last 365 days: 1547 accesses
  • All time: 4823 accesses

Cited by

BioMed Central: 3 citations

Opinion   Open Access

Biomarkers of acute lung injury: worth their salt?

Alastair G Proudfoot, Matthew Hind, Mark JD Griffiths BMC Medicine 2011, 9:132 (12 December 2011)

This article is part of a collection on Clinical biomarkers

Griffiths and colleagues discuss the role of biomarkers in the management of acute lung injury, a life-threatening form of hypoxemic respiratory failure, and critically examine the current strategies used to identify biomarkers.

Letter   Free Highly Accessed

In critically ill patients the procalcitonin level can be misleading

Jacqueline Koeze, MG Ron Hendrix, Frank AJTM van den Bergh, René ML Brouwer, Jan G Zijlstra Critical Care 2011, 15:422 (28 April 2011)

Commentary   Free Highly Accessed

What procalcitonin brings to management of sepsis in the ICU

Michel Wolff, Lila Bouadma Critical Care 2010, 14:1007 (1 December 2010)